Declaration of patent applications as financial interests: a survey of practice among authors of papers on molecular biology in Nature

Objectives: To determine whether authors of scientific publications in molecular biology declare patents and other potential financial interests. Design: Survey of a 6-month sample of papers related to molecular biology in Nature. Methods: The esp@cenet worldwide patent search engine was used to search for patents applied for by the authors of scientific papers in Nature that were related to molecular biology and genetics, between January and June 2005. Results: Of the 79 papers considered, four had declared that certain authors had competing financial interests. Seven papers in which no financial interests were declared had authors with patent applications that were based on the research in the paper or were closely related to it. Another paper had two authors with connections to biotechnology companies that were not disclosed. Conclusion: Two thirds of the papers in which authors had patent applications or company affiliations that might be considered to be competing financial interests did not disclose them. Failure to disclose such information may have negative implications on the perception of science in society and on its quality if the possible bias is hidden. Journals should make greater efforts to ensure full disclosure, and scientific institutions should consider failure to disclose financial interests as an example of scientific malpractice. Establishing a register of interests for scientists is one way to increase transparency and openness.

[1]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[2]  A. Venkitaraman Medicine: Aborting the birth of cancer , 2005, Nature.

[3]  R. Hotz Book Review: Science in the Private Interest: Has the Lure of Profits Corrupted Biomedical Research? , 2004 .

[4]  J. Kang,et al.  Transgenic mice: Fat-1 mice convert n-6 to n-3 fatty acids , 2004, Nature.

[5]  S. Krimsky,et al.  Science in the private interest: has the lure of profits corrupted biomedical research? , 2006, IEEE Technology and Society Magazine.

[6]  Jeffrey C. Miller,et al.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases , 2005, Nature.

[7]  M. Goozner Unrevealed: Non-Disclosure of Conflicts of Interest In Four Leading Medical and Scientific Journals , 2004 .

[8]  Karl-Ludwig Laugwitz,et al.  Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages , 2005, Nature.

[9]  Frank van Kolfschooten Conflicts of interest: Can you believe what you read? , 2002, Nature.

[10]  Stephen P. Jackson,et al.  Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage , 2005, Nature.

[11]  Alan Ashworth,et al.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.

[12]  Toby Lawrence,et al.  IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation , 2005, Nature.

[13]  Thomas Helleday,et al.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase , 2005, Nature.

[14]  S. Kappe,et al.  Genetically modified Plasmodium parasites as a protective experimental malaria vaccine , 2005, Nature.

[15]  C. Gross,et al.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review. , 2003, JAMA.

[16]  Fan Yang,et al.  R gene expression induced by a type-III effector triggers disease resistance in rice , 2005, Nature.

[17]  Catherine D DeAngelis,et al.  Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. , 2005, JAMA.

[18]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[19]  Ermenegyldo Munhoz Junior Requisitos uniformes para manuscritos submetidos a periódicos biomédicos: escrevendo e editando para publicações biomédicas , 2006 .

[20]  C. Mummery Cardiology: Solace for the broken-hearted? , 2005, Nature.

[21]  N. Ryba,et al.  The receptors and coding logic for bitter taste , 2005, Nature.

[22]  H. Ma,et al.  Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis , 2005, Nature.

[23]  R. Ménard Medicine: Knockout malaria vaccine? , 2005, Nature.

[24]  K. Chien,et al.  Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages , 2007, Nature.